Ki-67 expression in operable breast cancer: A comparative study of immunostaining and a real-time RT-PCR assay

Pathology Research and Practice

Volumn 202, Issue 7, 2006, Pages 491-495

  Potemski, Piotr ^a   Pluciennik, Elzbieta ^a   Bednarek, Andrzej K ^a   Kusinska, Renata ^a   Kubiak, Robert ^a   Jesionek Kupnicka, Dorota ^a   Watala, Cezary ^a   Kordek, Radzislaw ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Breast cancer; Immunostaining; Ki 67; Real time RT PCR; Survival

Indexed keywords

ANTHRACYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE; KI 67 ANTIGEN;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIVARIATE ANALYSIS; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

EID: 33745021835     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.02.005     Document Type: Article

References (23)

1. Barbareschi M., Leonardi E., Mauri F.A., Serio G., and Dalla Palma P. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Am. J. Clin. Pathol. 98 (1992) 408-418
2. Brown D.C., and Gatter K.C. Ki67 protein: the immaculate deception?. Histopathology 40 (2002) 2-11
3. Cattoretti G., Becker M.H., Key G., Duchrow M., Schluter C., Galle J., and Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol. 168 (1992) 357-363
4. Colozza M., Azambuja E., Cardoso F., Sotiriou C., Larsimont D., and Piccart M.J. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?. Ann. Oncol. 16 (2005) 1723-1739
5. de Cremoux P., Bieche I., Tran-Perennou C., Vignaud S., Boudou E., Asselain B., Lidereau R., Magdelenat H., Becette V., Sigal-Zafrani B., and Spyratos F. Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction. Endocr. Relat. Cancer. 11 (2004) 489-495
6. Duchrow M., Ziemann T., Windhovel U., Bruch H.P., and Broll R. Colorectal carcinomas with high MIB-1 labelling indices but low pKi67 mRNA levels correlate with better prognostic outcome. Histopathology 42 (2002) 566-574
7. Esteva F.J., Sahin A.A., Cristofanilli M., Coombes K., Lee S.J., Baker J., Cronin M., Walker M., Watson D., Shak S., and Hortobagyi G.N. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Clin. Cancer. Res. 11 (2005) 3315-3319
8. Gasparini G., Dal Fior S., Pozza F., and Bevilacqua P. Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma. Breast. Cancer. Res. Treat. 14 (1989) 329-336
9. Gerdes J., Schwab U., Lemke H., and Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer. 15 (1983) 13-20
10. Haerslev T., Jacobsen G.K., and Zedeler K. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas. Breast. Cancer. Res. Treat. 37 (1996) 101-113
11. Keshgegian A.A., and Cnaan A. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1,. Am. J. Clin. Pathol. 104 (1995) 42-49
12. Kronqvist P., Kuopio T., Nykanen M., Helenius H., Anttinen J., and Klemi P. Predicting aggressive outcome in T1N0M0 breast cancer. Br. J. Cancer. 91 (2004) 277-2781
13. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
14. McCarty Jr. K.S., Miller L.S., Cox E.B., Konrath J., and McCarty Sr. K.S. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109 (1985) 716-721
15. Mirza A.N., Mirza N.Q., Vlastos G., and Singletary S.E. Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann. Surg. 235 (2002) 10-26
16. Mitas M., Mikhitarian K., Walters C., Baron P.L., Elliott B.M., Brothers T.E., Robison J.G., Metcalf J.S., Palesch Y.Y., Zhang Z., Gillanders W.E., and Cole D.J. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Cancer. 93 (2001) 162-171
17. Molino A., Micciolo R., Turazza M., Bonetti F., Piubello Q., Bonetti A., Nortilli R., Pelosi G., and Cetto G.L. Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis. Int. J. Cancer. 74 (1997) 433-437
18. Sahin A.A., Ro J., Ro J.Y., Blick M.B., El-Naggar A.K., Ordonez N.G., Fritsche H.A., Smith T.L., Hortobagyi G.N., and Ayala A.G. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer 68 (1991) 549-557
19. Trihia H., Murray S., Price K., Gelber R.D., Golouh R., Goldhirsch A., Coates A.S., Collins J., Castiglione-Gertsch M., and Gusterson B.A. Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker?. Cancer 97 (2003) 1321-1331
20. Urruticoechea A., Smith I.E., and Dowsett M. Proliferation marker Ki-67 in early breast cancer. J. Clin. Oncol. 23 (2005) 7212-7220
21. Veronese S.M., Gambacorta M., Gottardi O., Scanzi F., Ferrari M., and Lampertico P. Proliferation index as a prognostic marker in breast cancer. Cancer 71 (1993) 3926-3931
22. Weikel W., Beck T., Mitze M., and Knapstein P.G. Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67. Breast. Cancer. Res. Treat. 18 (1991) 149-154
23. Weikel W., Brumm C., Wilkens C., Beck T., and Knapstein P.G. Growth fractions (Ki-67) in primary breast cancers. with particular reference to node-negative tumors, Cancer Detect. Prev. 19 (1995) 446-450